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Abstract
Background: Telomere length is associated with several physical and mental health conditions, but whether it is a marker
of multimorbidity is unclear. We investigated associations between telomere length and multimorbidity by sex.
Methods: Data from adults (N = 5,495) aged ≥50 years were taken from the US Health and Retirement Study (2008–14).
Telomere length was measured in 2008 from salivary samples. The cross-sectional associations between telomere length and
eight chronic health conditions were explored using logistic regression, adjusting for confounders and stratiﬁed by sex.
Logistic, ordinal and multinomial regression models were calculated to explore relationships between telomere length and
multimorbidity (using a binary variable and a sum of the number of health conditions) and the type of multimorbidity (no
multimorbidity, physical multimorbidity, or multimorbidity including psychiatric problems). Using multilevel logistic regres-
sion, prospective relationships between telomere length and incident multimorbidity were also explored.
Results: In cross-sectional analyses, longer telomeres were associated with reduced likelihood of lung disease and psychi-
atric problems among men, but not women. Longer telomeres were associated with lower risk of multimorbidity that
included psychiatric problems among men (OR=0.521, 95% CI: 0.284 to 0.957), but not women (OR=1.188, 95% CI:
0.771 to 1.831). Prospective analyses suggested little association between telomere length and the onset of multimorbidity in
men (OR=1.378, 95% CI: 0.931 to 2.038) nor women (OR=1.224, 95% CI: 0.825 to 1.815).
Conclusions: Although telomere length does not appear to be a biomarker of overall multimorbidity, further exploration
of the relationships is merited particularly for multimorbidity including psychiatric conditions among men.
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Key points
• Few studies have investigated whether telomere length is a biomarker of multimorbidity
• Telomere length was not related to overall multimorbidity
• Among men, longer telomeres were associated with reduced risk of multimorbidity that included psychiatric problems
Introduction
Multimorbidity (the coexistence of two or more chronic
diseases) is an increasing global public health concern [1].
The prevalence of multimorbidity increases with age and
affects over half of the older population [2]. It is associated
with heightened mortality risk, decreased physical function-
ing and quality of life, and higher levels of inpatient and
698
C. L. Niedzwiedz et al.
D
ow
nloaded from
 https://academ
ic.oup.com
/ageing/article-abstract/48/5/703/5511442 by U
niversity of G
lasgow
 user on 16 O
ctober 2019
ambulatory healthcare [2, 3]. Multimorbidity is inﬂuenced
by a number of social and lifestyle factors [4]; for example,
women and individuals experiencing a disadvantaged socio-
economic position display an increased prevalence [2, 3].
However, to date, few studies have examined potential bio-
logical factors associated with multimorbidity. Improved
understanding of the biological mechanisms that lead to the
development of chronic diseases and multimorbidity is key
to the development of new personalised treatments, preven-
tion, and the reduction of escalating healthcare costs [5].
Telomere length has been widely proposed as a potential
marker of biological ageing [6–8]. Telomeres are repetitive
nucleotide sequences (of TTAGGG) at the end of chromo-
somes that protect the genome from damage and shorten
with each cell division. Meta-analyses demonstrate that
shorter telomeres are associated with a range of health out-
comes, including cardiovascular disease [9], psychiatric dis-
orders [10], and cancer [11]. However, the majority of
included studies are limited by their cross-sectional design
and few studies have examined telomere length in relation
to multimorbidity [12].
It is plausible that telomere length could be a biomarker
for multimorbidity and that shorter telomeres increase the
risk of developing multimorbidity, with longer telomeres
being potentially protective. A key factor that may inﬂuence
this potential relationship is sex. Telomeres tend to be long-
er amongst women compared to men, with little evidence
for any difference by age group [13]. This relationship is
thought to be related to the actions of oestrogen and oxida-
tive stress [13]. Oestrogen stimulates the production of tel-
omerase, which is thought to protect against reactive
oxygen species damage [14]. As multimorbidity tends to be
more common in females, it is possible that any association
between multimorbidity and telomere length may be modi-
ﬁed by sex.
In this study we explore the relationships between telo-
mere length and multimorbidity in cross-sectional and pro-
spective analyses, using data from the US Health and
Retirement Study and investigate potential differences by
sex. We have three main objectives: (1) Examine the indi-
vidual cross-sectional associations between telomere length
and a number of chronic diseases; (2) Explore whether telo-
mere length is related to multimorbidity in cross-sectional
analyses, using different operationalisations of multimorbid-
ity; (3) Prospectively investigate whether telomere length
predicts the development of incident multimorbidity.
Method
Data
The Health and Retirement Study (HRS) is a nationally rep-
resentative longitudinal survey of individuals aged over age
50 years in the USA. It began in 1992 and has continued to
collect data every two years on the health and economic cir-
cumstances associated with ageing [15]. In 2008 (wave 9)
the telomere lengths of 5,808 respondents who provided
consent for a saliva sample were measured [16]. The HRS
2008 Telomere dataset is sponsored by the National
Institute on Aging (grant number NIA U01AG009740) and
the study was conducted by the University of Michigan
[17]. The 2008 telomere data were linked to the RAND
HRS dataset [18], which combines data for the 2008, 2010,
2012 and 2014 HRS waves. We included individuals aged
50 years and over (to represent older adults and those in
early old age) during the 2008 wave of HRS who provided
a saliva sample (N = 5,495), excluding individuals aged
under 50 years (N = 119) and who were ineligible due to
other reasons (e.g. living outside the U.S (N = 194)).
Deﬁnition of multimorbidity
Participants were asked whether they have ever been told
by a doctor that they had a health condition. The eight con-
ditions assessed were: (1) high blood pressure; (2) diabetes
or high blood sugar; (3) cancer or a malignant tumour
(excluding minor skin cancer); (4) chronic lung disease
(such as chronic bronchitis or emphysema); (5) a heart attack,
coronary heart disease, angina, congestive heart failure, or
other heart problems; (6) stroke; (7) emotional, nervous, or
psychiatric problems; and (8) arthritis or rheumatism. A bin-
ary variable distinguishing those with no multimorbidity
(none or one health condition) from those with multimorbid-
ity (two or more health conditions) was generated and a mul-
timorbidity score was created by summing the number of
conditions present. This was top-coded at six due to the small
number of individuals with seven or eight conditions when
stratiﬁed by sex. We also categorised participants into groups
depending on the type of multimorbidity: no multimorbidity
(none or one health condition); physical multimorbidity (two
or more physical health conditions); or multimorbidity includ-
ing psychiatric problems (psychiatric problems and one or
more physical health conditions).
Telomere length
Telomere length data was obtained from the HRS 2008
Telomere dataset, which has been analysed previously in a
number of studies [19, 20]. The telomeres were assayed
using quantitative Polymerase Chain Reaction (qPCR) [21],
which compared the telomere sequence copy number in
each individual’s sample (T) to a single-copy gene copy
number (S), producing a T/S ratio which is proportional to
telomere length. The assays were conducted by Telome
Health (Telomere Diagnostics, http://www.telomehealth.
com/). Due to the positive skew we log transformed (using
natural logarithm) the telomere length variable.
Covariates
Age (years), ethnicity (non-Hispanic white, non-Hispanic
Black, Hispanic, Other), education level (less than high
school, high school or General Education Diploma (GED),
some college, college or above), smoking (never smoked,
previous smoker, current smoker) and body mass index (as
Sex differences in the association between salivary telomere length and multimorbidity
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a continuous variable) were included as covariates. A GED
demonstrates a level of knowledge equivalent to a high
school graduate. We investigated sex (male or female) as a
potential moderating variable as we hypothesised the asso-
ciations may be different between men and women. All
statistical models also controlled for the plate number used
to assay telomere length based on the different dilution fac-
tors used [22].
Statistical analyses
Descriptive statistics for each variable were ﬁrst examined
using the cross-sectional data from 2008. The analyses fol-
lowed a number of steps in line with our objectives
described in the introduction. (1) We examined the cross-
sectional age-adjusted relationships between telomere length
(logged) and each of the eight health conditions in a series
of logistic regression models and then adjusted for the add-
itional covariates. These models were stratiﬁed by sex as
interaction terms between telomere length and sex were
statistically signiﬁcant (P < 0.05) and to examine potential
differences between men and women. (2) We then calcu-
lated logistic regression models predicting multimorbidity
using a binary variable distinguishing those with and with-
out multimorbidity (two or more health conditions versus
none or one health condition). Using ordinal regression we
then examined the association between telomere length
(logged) and the sum of the number of health conditions
present. Then, using multinomial regression we predicted
the type of multimorbidity (no multimorbidity, physical
multimorbidity, or multimorbidity including psychiatric pro-
blems) according to logged telomere length. For each
operationalisation of multimorbidity we ﬁrst calculated age-
adjusted models, followed by models adjusting for the add-
itional covariates. (3) We then investigated the prospective
association between telomere length in 2008 and the devel-
opment of multimorbidity during 2010 to 2014 (the follow-
ing three waves) amongst individuals who were not
multimorbid at baseline in 2008. The data were converted
to long format and multilevel logistic regression models
were calculated using logged telomere length as the explana-
tory variable and the development of multimorbidity (none
or one health condition versus two or more health condi-
tions) as the binary outcome variable. The models were
stratiﬁed by sex and included waves nested within indivi-
duals, calculated using Stata’s xtlogit command. Due to the
small sample size and lack of power we were unable to
explore telomere length in relation to the onset of multi-
morbidity including psychiatric problems.
Sensitivity analyses were conducted excluding the partici-
pants (N = 270) with a telomere T/S ratio above 2.0, as
these high values may be due to artefact in saliva samples
[20]. Survey weights were used in the analyses to make the
survey representative of the community-based population
and the standard errors were adjusted for household clus-
tering. A complete case analysis was performed excluding
missing data for the covariates. For all cross-sectional
analyses we included the same number of individuals in
each model (2,272 men and 3,083 women). Analyses were
performed using Stata/MP 15.1.
Results
Sample description
A total of 5,355 individuals (excluding those with missing
covariate data, N = 140) were included in the cross-
sectional sample, which was 55.2% female (Table 1). The
mean age of participants was 66.8 years for men and 67.6
years for women, ranging from 50 to 100 years. Only
15.5% of men and 13.2% of women reported no health
conditions at baseline. 23.8% of men and 24.6% of women
had one condition, with 60.7% and 62.1% reporting multi-
morbidity (two or more health conditions). 48.9% of men
and 44.4% of women had physical multimorbidity, and
11.8% of men and 17.7% of women had multimorbidity
with psychiatric problems.
Cross-sectional relationship between telomere
length and chronic health conditions
In age-adjusted models, longer telomeres were associated with
reduced likelihood of lung disease for both men (OR=0.494,
95% CI: 0.277 to 0.883) and women (OR=0.522, 95% CI:
0.321 to 0.849) (Table 2, full results in Supplementary
Tables S1 and S2). Longer telomeres were also related to the
decreased likelihood of psychiatric problems among men only
(OR=0.535, 95% CI: 0.303 to 0.945). Among men, once the
models were adjusted for the additional covariates, the asso-
ciations between telomere length, lung disease and psychiatric
problems persisted. However, among women, adjustment for
the covariates attenuated the association between telomere
length and lung disease such that it was no longer statistically
signiﬁcant (Table 2). Among both genders, longer telomeres
were also related to reduced likelihood of arthritis, cancer and
heart problems, but these associations were not statistically
signiﬁcant.
Cross-sectional relationship between telomere
length and multimorbidity
In the cross-sectional logistic regression analyses, telomere
length was related to reduced likelihood of multimorbidity
in men (OR=0.884, 95% CI: 0.628 to 1.246) and women
(OR=0.972, 95% CI: 0.721 to 1.311), but these associations
were not statistically signiﬁcant when using the binary multi-
morbidity variable as the outcome (Table 2). Similar results
were found for men when using the number of conditions
as the outcome and conducting ordinal regression. When
examining the association between telomere length and the
type of multimorbidity, we ﬁnd that among men, longer tel-
omeres were related to lower risk of multimorbidity includ-
ing psychiatric problems, compared to no multimorbidity
(RRR = 0.521, 95% CI: 0.284 to 0.957). This association
persisted when adjusting for the covariates. The association
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also remained after changing the baseline referent category
to physical multimorbidity. There was little association
found between telomere length and the type of multimor-
bidity among women. Sensitivity analysis excluding partici-
pants with a T/S ratio of above 2 did not affect the
substantive results.
Prospective association between telomere length
and multimorbidity
A total of 1,989 individuals (59.0% women) had no multi-
morbidity at baseline in wave 9. By wave 12, 602 individuals
had developed multimorbidity. In age-adjusted multilevel
logistic regression models (Table 3), telomere length was
not associated with the development of multimorbidity
(deﬁned as two or more health conditions) for either sex
and the direction of the association was in the opposite to
that expected if shorter telomeres predispose the develop-
ment of multimorbidity. Among men, only increased age
was associated with the development of multimorbidity
(OR=1.035, 95% CI: 1.021 to 1.050). Both increased age
(OR=1.035, 95% CI: 1.023 to 1.047) and BMI (OR=1.036,
95% CI: 1.015 to 1.057) were related to the onset of multi-
morbidity among women.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Descriptive statistics for the sample (weighted %s)
Male Female
Mean SD Mean SD
Age 66.8 9.4 67.6 9.9
Body mass index 28.4 5.2 28.2 6.5
Telomere lengtha 1.29 0.37 1.32 0.36
Education level N % N %
< High School 459 16.4 667 17.9
High school or General Education Diploma 706 29.0 1,188 38.0
Some college 489 24.3 706 24.6
College and above 618 30.3 522 19.5
Ethnicity
Non-Hispanic white 1,753 81.3 2,272 79.7
Non-Hispanic Black 266 8.1 451 9.9
Hispanic 206 8.0 296 8.1
Other 47 2.6 64 2.3
Smoking status
Never smoked 720 32.7 1,567 50.5
Previous smoker 1,251 52.2 1,139 36.2
Current smoker 301 15.1 377 13.3
Health conditions (N and % with condition)
Psychiatric problems 246 12.9 561 19.1
High blood pressure 1,349 55.7 1,838 55.5
Arthritis 1,235 51.6 2,129 65.9
Diabetes 557 22.2 590 17.6
Stroke 242 8.8 224 6.7
Cancer 395 14.5 467 14.4
Lung disease 218 8.5 323 9.9
Heart problems 722 27.7 692 20.5
No. of health conditions
0 285 15.5 322 13.2
1 496 23.8 722 24.6
2 606 26.4 832 25.9
3 492 19.7 678 20.3
4 239 8.9 325 9.6
5 106 3.8 134 4.2
6+ 48 1.9 70 2.0
Multimorbidity
No (none or 1 health condition) 781 39.3 1,044 37.9
Yes (2 or more health conditions) 1,491 60.7 2,039 62.1
Multimorbidity type
None (none or 1 health condition) 781 39.3 1,044 37.9
Physical multimorbidity (2 or more physical health conditions) 1,259 48.9 1,512 44.4
Multimorbidity including psychiatric problems
(2 or more health conditions that include psychiatric problems)
232 11.8 527 17.7
Total 2,272 44.8 3,083 55.2
aGeometric mean and interquartile range. N=number of individuals; SD=standard deviation.
Sex differences in the association between salivary telomere length and multimorbidity
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Table 2. Associations between telomere length (logged) and health outcomes among 2,272 men and 3,083 women in the Health and Retirement Study
Psychiatric
problems
High blood
pressure
Arthritis Diabetes Stroke Cancer Lung disease Heart
problems
Multimorbidity
(no vs. yes)a
Multimorbidity (no. of
health conditions)
Physical
multimorbiditya
Multimorbidity including
psychiatric problemsa
Logistic regression models Ordinal regression
model
Multinomial regression model
OR OR OR OR OR OR OR OR OR OR RRR RRR
[95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI] [95% CI]
Age adjusted
Men 0.535* 1.144 0.898 1.258 0.936 0.739 0.494* 0.766 0.884 0.872 1.016 0.521*
Telomere
length
(logged)
[0.303,0.945] [0.824,1.587] [0.646,1.249] [0.800,1.978] [0.545,1.605] [0.480,1.136] [0.277,0.883] [0.535,1.096] [0.628,1.246] [0.661,1.151] [0.703,1.468] [0.284,0.957]
Women 1.178 1.160 0.982 1.366 1.457 0.692 0.522** 0.877 0.972 1.004 0.886 1.188
Telomere
length
(logged)
[0.802,1.730] [0.867,1.552] [0.732,1.317] [0.955,1.955] [0.929,2.286] [0.479,1.001] [0.321,0.849] [0.613,1.254] [0.721,1.311] [0.778,1.296] [0.647,1.213] [0.771,1.831]
Adjusted for additional covariates1
Men 0.521* 1.061 0.863 1.056 0.890 0.701 0.529* 0.760 0.850 0.774 0.975 0.496*
Telomere
length
(logged)
[0.291,0.933] [0.756,1.490] [0.621,1.199] [0.656,1.701] [0.529,1.496] [0.462,1.064] [0.311,0.900] [0.531,1.089] [0.597,1.209] [0.585,1.023] [0.669,1.421] [0.268,0.919]
Women 1.344 1.044 0.964 1.156 1.351 0.690 0.681 0.888 0.922 0.967 0.806 1.247
Telomere
length
(logged)
[0.924,1.955] [0.756,1.442] [0.707,1.315] [0.807,1.656] [0.895,2.040] [0.465,1.022] [0.434,1.069] [0.633,1.245] [0.664,1.279] [0.749,1.248] [0.572,1.135] [0.801,1.942]
1Adjusted for age (years), ethnicity, education level, smoking status, Body Mass Index and plate number.
aNo multimorbidity (none or one health condition) is the referent group.
CI=conﬁdence interval; OR=odds ratio; RR=relative risk ratio. * p < 0.05, ** p < 0.01, *** p < 0.001.
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Discussion
We hypothesised that telomere length could act as a bio-
marker of multimorbidity. However, there was little overall
evidence to support this hypothesis. Among both men and
women, longer telomeres related to the reduced likelihood
of lung disease, but this association was attenuated among
women after adjustment for potential confounding factors.
For men, longer telomeres were also associated with the
decreased likelihood of psychiatric problems, an association
that persisted following adjustment for covariates. No evi-
dence was found for an association between telomere
length and multimorbidity among women. Findings were
similar for men apart from when distinguishing between
the types of multimorbidity. Longer telomeres were related
to the reduced risk of multimorbidity including psychiatric
problems, compared to no multimorbidity (which may have
included psychiatric problems as a singular condition), and
this association was not observed for men with physical
multimorbidity. In the prospective analyses, telomere length
was not related to the onset of multimorbidity for men or
women. Although this suggests that telomere length is not
predictive of the onset of multimorbidity, this may be due
to a lack of statistical power. Further prospective research
with larger sample sizes and repeated telomere length
measurements to record change, as well as meta-analyses
and studies that assess causality (e.g. using a Mendelian
Randomisation approach) are required to fully understand
the relationships between telomere length, psychiatric pro-
blems and comorbid physical conditions.
We observed that longer telomeres were related to
reduced likelihood of lung disease and psychiatric problems
among men in cross-sectional analyses. This is consistent
with previous research demonstrating that shorter telo-
meres tend to be found amongst people with psychiatric ill-
ness, particularly depressive disorders [10]. Previous studies
have also demonstrated a modest association between
shorter telomeres, lung function and chronic obstructive
pulmonary disease [19, 23]. The sex differences noted in
our study have been observed in other studies examining
the relationship between telomere length and psychiatric
disorders. For example, in a prospective study investigating
depression, generalised anxiety disorder, post-traumatic
stress disorder and telomere erosion, Shalev et al. found
associations among men but not women [24]. They suggest
that men may be more prone than women to physiological
changes related to psychiatric disorders, which are also
implicated in telomere function [24], such as the
hypothalamic-pituitary-adrenal axis response to stress [25],
elevated proinﬂammatory cytokines [26], and greater
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3. Multilevel logistic regression model results predicting the development of multimorbidity (2 or more health condi-
tions, referent category is none or one health condition)
Men Women
Model 1 Model 2 Model 1 Model 2
OR OR OR OR
[95% CI] [95% CI] [95% CI] [95% CI]
Telomere length (logged) 1.378 1.276 1.224 1.279
[0.931,2.038] [0.858,1.897] [0.825,1.815] [0.865,1.892]
Age (years) 1.034*** 1.035*** 1.027*** 1.035***
[1.021,1.048] [1.021,1.050] [1.016,1.038] [1.023,1.047]
Education Level (ref = < high school)
High school or General Education Diploma 0.939 1.058
[0.630,1.400] [0.751,1.493]
Some college 0.833 0.895
[0.535,1.297] [0.615,1.303]
College & above 0.911 1.192
[0.601,1.379] [0.807,1.761]
Body Mass Index 1.015 1.036***
[0.987,1.045] [1.015,1.057]
Smoking status (ref=never smoked)
Previous smoker 1.020 0.889
[0.772,1.349] [0.695,1.136]
Current smoker 1.066 1.272
[0.713,1.594] [0.909,1.780]
Ethnicity (ref=Non-Hispanic white)
Non-Hispanic Black 0.937 1.251
[0.616,1.425] [0.895,1.749]
Hispanic 1.222 1.295
[0.797,1.873] [0.892,1.881]
Other 0.681 1.091
[0.323,1.435] [0.513,2.319]
CI=conﬁdence interval; OR=odds ratio. * p < 0.05, ** p < 0.01, *** p < 0.001.
Model 1: Adjusted for age; Model 2: Adjusted for age, ethnicity, education level, smoking status, Body Mass Index and plate number.
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oxidative stress markers [27]. More recent evidence from
Mendelian Randomisation studies suggest a more compli-
cated picture. Longer telomeres were associated with the
increased risk of several types of cancer, shorter telomeres
related to increased risk of cardiovascular disease and inter-
stitial lung disease, but little evidence was found for psychi-
atric disorders [28], suggesting observational studies are
likely to be affected by confounding and reverse causation.
Strengths and limitations
An important strength of our study is the relatively large
sample size allowing stratiﬁcation by sex. Our study was
also multi-ethnic and included both cross-sectional and pro-
spective analyses. It is possible that relationships could dif-
fer by ethnicity, which we have not explored in this study.
Whilst numerous studies have investigated the association
between single diseases and telomere length, few have
examined multimorbidity speciﬁcally. However, our study is
limited by the self-reported nature of the phenotype data,
which may be subject to recall bias. As participants were
not asked about every physical or mental health condition
that they had experienced, it is possible that some respon-
dents had other conditions that were not recorded. The
questionnaire item relating to psychiatric problems was also
broad and did not assess the severity of condition, or
whether participants had experienced multiple mental health
conditions. This was also an issue for some of the other
disease categories, such as cancer, with previous research
demonstrating that different types of cancer may have vari-
able relationships with telomere length [28]. Due to the
high proportion of individuals with multimorbidity at base-
line, our prospective analyses also lacked power. In add-
ition, the results may not be generalisable to those aged
under 50 years. Telomeres were also only measured at one
time point and it is possible that the cross-sectional rela-
tionships found in this study may be subject to reverse
causality and confounding. Future studies could investigate
the direction of causality using a Mendelian Randomisation
approach [28]. Our study also only analysed telomere length
derived from saliva samples. It is possible that different
results may be obtained from other tissue types (e.g. venous
blood) as different cell types have varying rates of division
and therefore different rates of telomere attrition [29]. Few
previous studies have compared telomere lengths obtained
from blood and saliva [30], but those that have ﬁnd they
are correlated, with telomeres derived from salivary DNA
tending to be longer than those derived from blood sam-
ples [31, 32].
Conclusion
We examined the cross-sectional and prospective relation-
ships between telomere length and multimorbidity in a
cohort of older adults. In cross-sectional analyses, longer
telomeres were associated with reduced risk of multimor-
bidity that included psychiatric problems, among men only.
Prospective analyses did not ﬁnd telomere length to be pre-
dictive of the development of multimorbidity, but our ana-
lyses lacked statistical power. Further prospective studies
with larger samples and studies that assess the direction of
causality (e.g. via Mendelian Randomisation) are needed to
investigate the relationship between telomere length and
speciﬁc types of multimorbidity, such as psychiatric disor-
ders and cardiovascular disease.
Supplementary data mentioned in the text are available to
subscribers in Age and Ageing online.
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